Why the study?
Cardiovascular diseases remain a leading cause of mortality with significant disparities in Central and Eastern Europe, highlighting the need for effective prevention programs.
The EPP initiative advocates for a shift towards pre-disease prevention through mandatory health education, universal Lp(a) screening, and integrated care programs to reduce the CVD burden in Europe.
Answers are grounded in this paper and cite their sources.
May support targeted prevention in high-risk CEE populations; leaves open EPP impact on outcomes.
Cardiovascular diseases (CVDs) remain a leading global cause of mortality and disability, with significant disparities observed across countries. This is particularly true in Central and Eastern Europe (CEE), where populations are primarily at high and very high CVD risk. Highlighting modifiable risk factors underscores the urgent need for effective prevention programs. This paper introduces the European Program for Prevention (EPP), an initiative by the International Lipid Expert Panel (ILEP), designed to address these challenges. The EPP aims to enhance awareness and knowledge of validated preventive healthcare solutions implemented in CEE countries, showcase the region's potential for innovative strategies, and evaluate the adaptability of successful programs for broader implementation. The EPP strongly supports the EU Cardiovascular Health Plan, as well as initiatives by the World Heart Federation (WHF) and World Health Organization (WHO), by promoting best practices, early detection, integrated prevention frameworks, training, cross-border cooperation, and policy development. It advocates shifting healthcare priorities towards pre-disease prevention, thus reducing reliance on resource-intensive treatments. The program proposes an optimal CVD prevention system that includes mandatory health education, screening programs for familial hypercholesterolemia and universal Lp(a) screening, and comprehensive check-ups, notably integrated, comprehensive care programs. By leveraging existing validated programs and fostering collaboration, the EPP seeks to reduce the burden of CVD, improve outcomes, and promote cardiovascular health across Europe and beyond.
No takes yet. Share an insight, caveat, or question.
Banach et al. (2025) conducted an editorial in Cardiovascular diseases. European Program for Prevention (EPP) was evaluated. The European Program for Prevention (EPP) advocates for shifting healthcare priorities towards pre-disease prevention by implementing validated screening and educational programs across Europe.
Synapse has enriched 10 related papers. Consider them for comparative context: